Orion Porfolio Solutions LLC Purchases 6,032 Shares of The Clorox Company $CLX

18 Dec 2025, 11:08 by Danessa Lincoln · The Markets Daily

Orion Porfolio Solutions LLC increased its position in The Clorox Company (NYSE:CLX – Free Report) by 24.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,469 shares of the company’s stock after buying an additional 6,032 shares during the period. Orion Porfolio Solutions LLC’s holdings in Clorox were worth $3,658,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. MASTERINVEST Kapitalanlage GmbH purchased a new stake in shares of Clorox during the 2nd quarter worth approximately $532,000. Stance Capital LLC bought a new stake in Clorox in the second quarter worth $1,560,000. State of Wyoming raised its stake in Clorox by 4.7% during the second quarter. State of Wyoming now owns 2,540 shares of the company’s stock valued at $305,000 after purchasing an additional 113 shares in the last quarter. Hudson Bay Capital Management LP bought a new position in Clorox during the second quarter valued at $8,568,000. Finally, CYBER HORNET ETFs LLC bought a new position in Clorox during the second quarter valued at $39,000. 78.53% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Wells Fargo & Company reduced their target price on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 14th. The Goldman Sachs Group reduced their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research note on Wednesday, October 1st. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Finally, JPMorgan Chase & Co. cut their target price on Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 4th. One analyst has rated the stock with a Buy rating, thirteen have issued a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average target price of $125.00.

Read Our Latest Stock Report on Clorox

Clorox Stock Up 1.6%

Shares of NYSE CLX opened at $101.44 on Thursday. The Clorox Company has a 1 year low of $98.20 and a 1 year high of $165.00. The firm has a 50-day simple moving average of $108.77 and a two-hundred day simple moving average of $118.59. The company has a market cap of $12.37 billion, a P/E ratio of 15.93, a PEG ratio of 0.50 and a beta of 0.57. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50.

Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter in the prior year, the firm posted $1.86 earnings per share. The company’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.9%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is 77.86%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.